Colon and Rectal Cancer

• Immune therapeutics in gastric and colorectal cancer
• Adjuvant treatment for colon cancer: How to treat a stage III colon cancer?
• Adjuvant treatment for colon cancer: How to treat a T3N0M0 colon cancer?
• The European-Asian contribution of practice-changing in adjuvant chemotherapy of colon cancer: The IDEA study
• Delayed perforation after stent placement for sigmoid colon cancer obstruction
• Durable response to cetuximab plus FOXFOX in metastatic unresectable sigmoid colon cancer
• Rectal adenocarcinoma and ileocecal tuberculosis: A simple coincidence or a pathological co-existence?
• Prevention and Management of Low Rectal Anastomotic Leakage in The Robotic Era: A Propensity Score Matched Study
• Robot-assisted versus laparoscopic surgery for colorectal Cancer: short-term outcome of a retrospective comparative study
• Surgery versus Combined Surgery and Chemotherapy: Survival Patterns among Patients with Stage II Colorectal Adenocarcinoma
• NORTH/HGCSG1003 : A phase II study evaluating the safety and efficacy of FOLFOX as adjuvant chemotherapy for patients with stage III colon cancer :...
• Maintenance therapy with monthly tegafur-uracil for improving disease-free survival of patients with ypStage III rectal cancer
• Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer
• Long term outcomes of preoperative concurrent CapeOx/RT in locally advanced rectal cancer
• Efficacy and safety of S‑1‑based chemotherapy as first-line treatment in colorectal cancer: a meta-analysis of randomized controlled trials
• Is right-sided (sRt) BRAF mutated (mBRAF) metastatic colorectal cancer (mCRC) unresponsive to the 1st-line antiEGFR antibody treatment?
• The role of perioperative radiotherapy for patients with local recurrence of rectal cancer
• Comparative study: Side effects of Folfox4 and Folfiri for Colorectal Cancer Chemotherapy regiment in Margono Soekarjo Hospital, Purwokerto
• Phase 2 KEYNOTE-164 Study of Pembrolizumab (pembro) Monotherapy for Patients (pts) With Previously Treated, Mismatch Repair–Deficient (dMMR) Advanc...
• Effect On Oxaliplatin-Free Interval For Successful Rechallenge Of Oxaliplatin In Colorectal Cancer Patients Who Had Experienced An Oxaliplatin–Rela...
• HGCSG1503 : A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer : Analysis of...
• HGCSG1503 : A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer : Analysis of...
• Efficacy of Ramucirumab in combination with second-line or salvage-line FOLFIRI in patients with metastatic colorectal cancer.
• A China-Manufactured Bevacizumab Biosimilar, HLX04, Matches Avastin® Sourced from China, USA and European Union
• Safety and efficacy of trifluridine/tipiracil (TAS-102) plus bevacizumab in clinical practice for patients with refractory metastatic colorectal ca...

• « Previous
• 1
• 2
• ...
• 83
• Next »